Additionally, a recent study in Algeria on hereditary breast and ovarian cancer families reported only 7 carriers of BRCA1/2 pathogenic mutations out of 113 patients, representing 6.19%, which is lower than ours as well [40]. This evidence concerns the gene BRCA1 and ovarian carcinoma.